| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.26 | 8e-06 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.25 | 2e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.2 | 0.0004 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.19 | 0.0008 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.2 | 0.0008 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.004 |